Banque Transatlantique’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Sell
3,698
-27
-0.7% -$9.24K 0.03% 144
2026
Q1
$1.31M Buy
3,725
+2,394
+180% +$853K 0.03% 124
2025
Q4
$436K Sell
1,331
-249
-16% -$79K 0.01% 99
2025
Q3
$446K Hold
1,580
0.01% 99
2025
Q2
$442K Sell
1,580
-132
-8% -$37.4K 0.01% 93
2025
Q1
$533K Hold
1,712
0.02% 91
2024
Q4
$445K Buy
+1,712
New +$508K 0.01% 96

Other funds holding AMGN

Banque Transatlantique's AMGN Position: Q2 2026 in Review

Banque Transatlantique reduced its Amgen (AMGN) stake by 0.72% in Q2 2026, selling an estimated $9.24K and leaving 3,698 shares worth $1.31M. The position accounts for 0.03% of the portfolio, ranked #144.

Banque Transatlantique first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.31M in Q1 2026. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Banque Transatlantique held 3,698 shares of Amgen worth $1.31M as of Q2 2026.
  • Banque Transatlantique sold 27 Amgen shares in Q2 2026, an estimated $9.24K.
  • Amgen made up 0.03% of Banque Transatlantique's portfolio in Q2 2026, its #144 holding.
  • Banque Transatlantique first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • Banque Transatlantique's Amgen position peaked at $1.31M in Q1 2026.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.